These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7325626)

  • 1. Intraventricular levels of amikacin after intravenous administration.
    Yogev R; Kolling WM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):583-6. PubMed ID: 7325626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of amikacin in infants and pre-school children.
    Kafetzis DA; Sinaniotis CA; Papadatos CJ; Kosmidis J
    Acta Paediatr Scand; 1979 May; 68(3):419-22. PubMed ID: 443042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ceftriaxone by systemic route combined with amikacin by intraventricular route in the treatment of ventriculitis in children with hydrocephalus].
    Prado V; Zuleta A; Basauri L; Aguirre X
    Bol Med Hosp Infant Mex; 1984 Sep; 41(9):476-80. PubMed ID: 6093832
    [No Abstract]   [Full Text] [Related]  

  • 4. Penetrance of nafcillin into human ventricular fluid: correlation with ventricular pleocytosis and glucose levels.
    Yogev R; Schultz WE; Rosenman SB
    Antimicrob Agents Chemother; 1981 Apr; 19(4):545-8. PubMed ID: 7247377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amikacin concentration in the cerebrospinal fluid of children with acute bacterial meningitis.
    Trujillo H; Salgado H; Uribe A; Agudelo N; Zapata CT; Luisa de Vidal E; Zuluaga AI
    J Int Med Res; 1979; 7(1):45-51. PubMed ID: 421964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and efficacy of an aminoglycoside administered into the cerebral ventricles in neonates: implications for further evaluation of this route of therapy in meningitis.
    Wright PF; Kaiser AB; Bowman CM; McKee KT; Trujillo H; McGee ZA
    J Infect Dis; 1981 Feb; 143(2):141-7. PubMed ID: 7012246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin pharmacokinetics in pediatric patients with malignancy.
    Cleary TG; Pickering LK; Kramer WG; Culbert S; Frankel LS; Kohl S
    Antimicrob Agents Chemother; 1979 Dec; 16(6):829-32. PubMed ID: 533263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition studies with amikacin after rapid intravenous and intramuscular administration to human volunteers.
    Yates RA; Mitchard M
    J Antimicrob Chemother; 1978 Jul; 4(4):335-41. PubMed ID: 690033
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of amikacin in the horse following intravenous and intramuscular administration.
    Orsini JA; Soma LR; Rourke JE; Park M
    J Vet Pharmacol Ther; 1985 Jun; 8(2):194-201. PubMed ID: 4020950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular administration of amikacin for complicated Gram-negative meningitis and ventriculitis.
    Wirt TC; McGee ZA; Oldfield EH; Meacham WF
    J Neurosurg; 1979 Jan; 50(1):95-9. PubMed ID: 363982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of amikacin in dogs.
    Baggot JD; Ling GV; Chatfield RC
    Am J Vet Res; 1985 Aug; 46(8):1793-6. PubMed ID: 4037511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological evaluation of amikacin in neonates.
    Howard JB; McCracken GH
    Antimicrob Agents Chemother; 1975 Jul; 8(1):86-90. PubMed ID: 1164009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous amikacin after rapid and slow infusion with special reference to hemodialysis.
    Pechere JC; Dugal R; Pechere MM
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):49-56. PubMed ID: 467467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular cerebrospinal fluid antibiotic concentrations in patients with intraventricular infections.
    James HE; Wilson HD; Connor JD; Walsh JW
    Neurosurgery; 1982 Jan; 10(1):50-4. PubMed ID: 7057978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kinetics of multiple-dose amikacin in the newborn infant].
    Olivesi A; Camboulives J; Charrel C; Unal D
    Ann Anesthesiol Fr; 1981; 22(2):212-8. PubMed ID: 6115610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of amikacin and gentamicin in volunteers: a comparison of individual differences.
    Walker JM; Wise R; Mitchard M
    J Antimicrob Chemother; 1979 Jan; 5(1):95-9. PubMed ID: 762009
    [No Abstract]   [Full Text] [Related]  

  • 17. [Penetration of amikacin into the anterior chamber of the human eye].
    Barrera V; Sinues B; Martinez P; Buatas A; Pinero A
    J Fr Ophtalmol; 1984; 7(8-9):539-43. PubMed ID: 6520334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification in the pharmacokinetics of amikacin during development.
    Lanao JM; Dominguez-Gil A; Dominguez-Gil AA; Málaga S; Crespo M; Nuño F
    Eur J Clin Pharmacol; 1982; 23(2):155-60. PubMed ID: 7140805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The necessity of increased doses of amikacin in burn patients.
    Zaske DE; Sawchuk RJ; Strate RG
    Surgery; 1978 Nov; 84(5):603-8. PubMed ID: 715674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative pharmacokinetics of amikacin after intravenous, intramuscular and subcutaneous administration].
    Leng B; Saux MC; Latrille J
    Nouv Presse Med; 1979 Oct; 8(42):3421-5. PubMed ID: 537887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.